Protagonist Therapeutics (PTGX) Times Interest Earned (2020)

Protagonist Therapeutics has reported Times Interest Earned for 11 years, with the latest figure at -$0.1 in Q4 2025.

• Quarterly Times Interest Earned fell 100.07% year-over-year to -$0.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.32 (down 100.07% YoY) and the FY2025 annual result came in at -$0.32, down 119.08% from the prior year.
• Times Interest Earned fell to -$0.1 in Q4 2025 per PTGX's latest filing, from $150.75 in the prior quarter.
• Over five years, Times Interest Earned peaked at $296.42 in Q1 2024 and troughed at -$55.3 in Q3 2023.
• A 5-year average of $16.04 and a median of -$0.57 in 2023 frame the typical range for Times Interest Earned.
• The sharpest annual moves came in 2022 and 2024: Times Interest Earned plunged 13564.51% in 2022, then jumped 52190.3% in 2024.
• Over 5 years, Times Interest Earned stood at $31.03 in 2021, then sank by 274.35% to -$54.1 in 2022, then jumped by 74.13% to -$13.99 in 2023, then soared by 1177.2% to $150.75 in 2024, then slumped by 100.07% to -$0.1 in 2025.
• According to Business Quant data, Times Interest Earned over the past three periods registered -$0.1, $150.75, and -$21.6 for Q4 2025, Q4 2024, and Q3 2024 respectively.